RediNews
ETFs Holding PTLA »    PTLA Historical Stock Prices »
PTLA News Video: Fri, Aug 24, 2018, 10:36 AM — Friday 8/24 Insider Buying Report: PTLA, AMTD


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Portola Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics in the areas of thrombosis, other hematologic disorders and inflammation. Co. is advancing three programs, including Bevyxxa® (betrixaban), an oral, once-daily Factor Xa inhibitor (anticoagulant), andexanet alfa, a recombinant protein designed to reverse the anticoagulant effect in patients treated with an oral or injectable fXa inhibitor, and cerdulatinib, a spleen tyrosine kinase (Syk) and Janus kinases inhibitor in development to treat hematologic cancers. Co. has a partnered program, which is focused on developing selective Syk inhibitors for inflammatory conditions. Self directed investors in Portola Pharmaceuticals, Inc. will be interested in keeping up with all Portola Pharmaceuticals, Inc. news they can find, both PTLA news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on PTLA. At RediNews, we simplify this task by presenting both PTLA news releases originating from Portola Pharmaceuticals, Inc. itself, and PTLA news from a variety of media outlets. Visitors can browse this news online and through our PTLA RSS news feed.

PTLA News

PTLA News — Articles, Videos, & Press Releases

XBI, ONCE, PBYI, PTLA: Large Inflows Detected at ETF
Tuesday, March 19, 2019, 10:53 AM — ETF Channel
Notable ETF Outflow Detected - XBI, ONCE, PBYI, PTLA
Monday, March 11, 2019, 10:46 AM — ETF Channel
Notable Friday Option Activity: ROKU, SHEN, PTLA
Friday, March 1, 2019, 3:21 PM — Stock Options Channel
SPDR S&P Biotech ETF Experiences Big Inflow
Wednesday, February 27, 2019, 10:58 AM — ETF Channel
First Week of PTLA April 18th Options Trading
Tuesday, February 26, 2019, 10:54 AM — Stock Options Channel
How The Parts Add Up: IYH Headed For $217
Friday, February 22, 2019, 9:58 AM — ETF Channel
XBI, MRTX, SAGE, PTLA: Large Inflows Detected at ETF
Tuesday, February 19, 2019, 10:52 AM — ETF Channel
PTLA Crosses Above Key Moving Average Level
Wednesday, February 13, 2019, 12:00 PM — Market News Video
Interesting PTLA Put And Call Options For September 20th
Tuesday, January 29, 2019, 10:35 AM — Stock Options Channel
Notable ETF Outflow Detected - XBI, MRTX, SAGE, PTLA
Friday, January 25, 2019, 10:47 AM — ETF Channel
Peek Under The Hood: IYY Has 14% Upside
Tuesday, January 22, 2019, 7:54 AM — ETF Channel
Interesting PTLA Put And Call Options For February 15th
Friday, January 4, 2019, 10:44 AM — Stock Options Channel
Portola Up as Large-Scale Andexxa Production Gets FDA Nod
Wednesday, January 2, 2019, 8:25 AM — Zacks
Noteworthy Thursday Option Activity: OMER, PTLA, BGS
Thursday, December 20, 2018, 3:17 PM — Stock Options Channel
Analysts Forecast 39% Upside For JKK
Thursday, December 20, 2018, 7:56 AM — ETF Channel
Notable Tuesday Option Activity: HTZ, NTAP, PTLA
Tuesday, December 11, 2018, 3:21 PM — Stock Options Channel
Analysts Anticipate JKK Will Reach $232
Monday, November 19, 2018, 7:27 AM — ETF Channel
Portola Pharmaceuticals is Now Oversold (PTLA)
Tuesday, November 6, 2018, 11:52 AM — Dividend Channel
First Week of June 2019 Options Trading For Portola Pharmaceuticals (PTLA)
Thursday, October 25, 2018, 11:02 AM — Stock Options Channel
The Math Shows IYH Can Go To $219
Friday, October 19, 2018, 7:49 AM — ETF Channel
Relative Strength Alert For Portola Pharmaceuticals
Thursday, October 11, 2018, 12:37 PM — Dividend Channel
First Week of November 16th Options Trading For Portola Pharmaceuticals (PTLA)
Thursday, September 27, 2018, 10:48 AM — Stock Options Channel
First Week of January 2021 Options Trading For Portola Pharmaceuticals (PTLA)
Tuesday, September 18, 2018, 11:28 AM — Stock Options Channel
Analysts See 11% Upside For The Holdings of JKK
Tuesday, September 18, 2018, 7:37 AM — ETF Channel
Top Buys by Directors: Bird's $10.1M Bet on PTLA
Friday, August 24, 2018, 11:04 AM — Dividend Channel
Interesting PTLA Put And Call Options For October 19th
Tuesday, August 21, 2018, 11:08 AM — Stock Options Channel
The Math Shows IEIH Can Go To $31
Friday, August 17, 2018, 9:17 AM — ETF Channel
Notable Thursday Option Activity: BREW, PTLA, MIC
Thursday, August 9, 2018, 3:20 PM — Stock Options Channel
Relative Strength Alert For Portola Pharmaceuticals
Thursday, August 9, 2018, 11:58 AM — Dividend Channel
Commit To Buy Portola Pharmaceuticals At $35, Earn 14.4% Annualized Using Options
Wednesday, July 25, 2018, 11:49 AM — Stock Options Channel
IYH's Holdings Imply 11% Gain Potential
Tuesday, July 17, 2018, 7:31 AM — ETF Channel
Analysts Anticipate IYH Will Reach $205
Thursday, June 14, 2018, 7:39 AM — ETF Channel
Short Interest Jumps 12.2% For PTLA
Tuesday, June 12, 2018, 1:45 PM — Market News Video
Notable Wednesday Option Activity: BOFI, NAV, PTLA
Wednesday, June 6, 2018, 3:18 PM — Stock Options Channel
Surprising Analyst 12-Month Target For SHE
Thursday, May 10, 2018, 9:29 AM — ETF Channel
Short Interest Increases 12% For PTLA
Tuesday, May 8, 2018, 10:10 PM — Market News Video
Noteworthy Monday Option Activity: PTLA, W, EHTH
Monday, April 30, 2018, 3:21 PM — Stock Options Channel
First Week of December 21st Options Trading For Portola Pharmaceuticals (PTLA)
Thursday, April 26, 2018, 10:51 AM — Stock Options Channel
Noteworthy Tuesday Option Activity: QDEL, RDI, PTLA
Tuesday, April 17, 2018, 3:19 PM — Stock Options Channel
Sum Up The Pieces: SHE Could Be Worth $79
Monday, April 9, 2018, 9:01 AM — ETF Channel
Noteworthy Wednesday Option Activity: GOOG, AAPL, PTLA
Wednesday, March 28, 2018, 3:33 PM — Stock Options Channel
PTLA is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

ANIP News
FCSC News
EGLT News
VCYT News
INGN News
TNDM News
ATEC News
BSTC News
ASPX News
EBIO News

Suppose you have experience with web publishing content and are starting a new financial website. You will have a stock index table with every major stock index you can think of, at the top you have the current market time and whether the markets are open or closed, and then you have a quote box where users can enter symbols to get a detailed quote like you would see on an investor relations quote page, along with historical stock quote information either in a stock table or stock market chart graphics. As you design your site, you may have a stock template created once and used for each possible stock ticker symbol, and you may have a stock price panel along the right-hand or left-hand column of other pages of your site. You've got mainly all your basis covered in terms of data, securing a stock market content provider for licensed quote content and historical stock data. But what about news? The same investor relations services providers that provide investor relations content can provide press releases but none of these investor relations tools contain third party articles. While third party articles can sometimes be critical of companies, that's what you want when looking for financial portal content, because corporate relations content designed for investor relations quotes pages is concerned with eliminating negativity and controversy. But third party news articles are critical for websites whose readers want to read all the news about the stocks they own, both published by the company and published by third parties. It is for this reason that RSS feeds by RediNews can add a compelling piece of additional dynamic content to your website. Look for the RSS icon on any news page within RediNews (which will look like this): to access our free RSS-based news feeds to supplement your web content.

PTLA News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.